Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...

-The Economist HOW should one judge the lot of women in India, a country that is in many ways progressive, modern, tolerant and yet by turns repressive and hostile? Women hold the highest political positions (the presidency, speaker of parliament, leader of the ruling party, leader of the opposition in parliament, several chief ministers of large states) and in theory they are protected by a variety laws promoting equality. Though development indicators...

-The Telegraph The Centre today asked a panel of doctors to outline measures to improve drug approval procedures, three days after a parliamentary standing committee said India’s drug regulators had broken laws, ignoring the interests of patients. The panel announced by the Union health ministry has been asked to suggest steps to improve the procedural aspects of the Central Drugs Standards Control Organisation (CDSCO), the agency entrusted with approving Medicines for sale...

Having watched from the ringside for many years now, I have no doubt in advising that the steering wheel must be firmly grasped by the government and direction given to policies that should be stable for at least the medium term. This is crucial for the growth of Indian pharma, a $20-billion industry growing at an average of 12% considering both domestic and export arenas. Price control: The biggest and most...

The Medical Council of India (MCI) has decided to take stern action against doctors who had endorsed scientific recommendations submitted to the Central Drugs Standard Control Organization (CDSCO), which were written by drug companies themselves. TOI reported on Thursday how drug companies have been caught red-handed writing scientific recommendations of their own drugs and submitting them to the Drug Controller General of India (DCGI) after getting them endorsed by reputed doctors...